You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-Tackling everyday challenges in cancer care, apply by September 28, 2020- NORTHBROOK, Ill., Aug. 4, 2020 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") today announced the call for entries...
Astellas "Golden Ticket" sponsorship provides access to life-science incubator and in-house Astellas expertise for scientific entrepreneurs with cutting-edge ideas CAMBRIDGE, Mass., July 23, 2020...
NORTHBROOK, Ill., May 27, 2020 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") announced today that the U.S. Food and Drug Administration...
NORTHBROOK, Ill., April 30, 2020 /PRNewswire/ -- With more and more Americans facing economic hardships as a result of the COVID-19 pandemic, Astellas has implemented changes to its patient...
- New Funding will Address Disparities in Mental Health Diagnosis and Treatment for 400,000 People in Need - NORTHBROOK, Ill. and INDIANAPOLIS, Feb. 10, 2020 /PRNewswire/ -- The Astellas Global...
Follow U.S. news
